CHA Biotech Co. Ltd Capital Reinvestment Ratio
CHA Biotech Co. Ltd capital reinvestment ratio. CHA Biotech Co. Ltd (085660) has a Capital Reinvestment Ratio of 2.52x as of June 2024, meaning it reinvests 3% of its operating cash flow (₩13.77 Billion) in capital expenditures (₩34.71 Billion). See free cash flow generation of CHA Biotech Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of CHA Biotech Co. Ltd (2009–2023)
Capital reinvestment ratio of CHA Biotech Co. Ltd from 2009 to 2023. This chart tracks CHA Biotech Co. Ltd's Capital Reinvestment Ratio across 13 annual periods. See CHA Biotech Co. Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CHA Biotech Co. Ltd Capital Reinvestment Ratio by Year (2009–2023)
CHA Biotech Co. Ltd capital reinvestment ratio by year from 2009 to 2023. For the full cash flow conversion analysis, see 085660 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 6.46x | ₩11.51 Billion | ₩74.38 Billion | ▲ +24.4% |
| 2021 | 5.19x | ₩22.23 Billion | ₩115.46 Billion | ▲ +93.4% |
| 2020 | 2.69x | ₩47.00 Billion | ₩126.23 Billion | ▼ -37.1% |
| 2019 | 4.27x | ₩25.24 Billion | ₩107.77 Billion | ▲ +311.9% |
| 2018 | 1.04x | ₩75.38 Billion | ₩78.14 Billion | ▼ -66.3% |
| 2017 | 3.07x | ₩12.01 Billion | ₩36.91 Billion | ▲ +1.7% |
| 2016 | 3.02x | ₩11.29 Billion | ₩34.13 Billion | ▲ +496.2% |
| 2015 | 0.51x | ₩61.86 Billion | ₩31.36 Billion | ▲ +20.8% |
| 2013 | 0.42x | ₩66.35 Billion | ₩27.85 Billion | ▼ -37.7% |
| 2012 | 0.67x | ₩45.77 Billion | ₩30.84 Billion | ▼ -8.2% |
| 2011 | 0.73x | ₩34.69 Billion | ₩25.48 Billion | ▲ +22.5% |
| 2010 | 0.60x | ₩42.07 Billion | ₩25.22 Billion | ▼ -19.7% |
| 2009 | 0.75x | ₩24.02 Billion | ₩17.93 Billion | — |